<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H38C986EB86D94E75A50B546806490A60" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 501 IH: Block, Report, And Suspend Suspicious Shipments Act </dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-01-25</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 501</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230125">January 25, 2023</action-date><action-desc><sponsor name-id="H001086">Mrs. Harshbarger</sponsor> (for herself and <cosponsor name-id="D000624">Mrs. Dingell</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HJU00">the Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Controlled Substances Act to require registrants to decline to fill certain suspicious orders, and for other purposes.</official-title></form><legis-body id="H2DD0235286EF4397B31CA95713889836" style="OLC"><section id="H69C69D4BF4844CBD81026A3C317ED46B" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Block, Report, And Suspend Suspicious Shipments Act </short-title></quote>.</text></section><section id="H6E3D324DD8A1495DB96C4A0783442699" section-type="subsequent-section"><enum>2.</enum><header>Block, report, and suspend suspicious orders</header><subsection id="H55653025F70547B58155530BC56C1C23"><enum>(a)</enum><header>Clarification of process for registrants To exercise due diligence upon discovering a suspicious order</header><text display-inline="yes-display-inline">Paragraph (3) of section 312(a) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/832">21 U.S.C. 832(a)</external-xref>) is amended to read as follows:</text><quoted-block display-inline="no-display-inline" id="H30347E746E2E4FB99B0A77E5FC9188DB" style="OLC"><paragraph id="HB20427008A2840E0BC629E1CF998970A"><enum>(3)</enum><text display-inline="yes-display-inline">upon discovering a suspicious order or series of orders, and in a manner consistent with the other requirements of this section—</text><subparagraph id="H6BDD75C94E4B46ABB7B8341D33AD266E"><enum>(A)</enum><text>exercise due diligence as appropriate;</text></subparagraph><subparagraph id="H423520BB57854AC88B6DA221CBD98CFB"><enum>(B)</enum><text>establish and maintain (for not less than a period to be determined by the Administrator of the Drug Enforcement Administration) a record of the due diligence that was performed;</text></subparagraph><subparagraph id="H0390F55CDE4D477DBC3AC17451CCF7C4"><enum>(C)</enum><text display-inline="yes-display-inline">decline to fill the order or series of orders if the due diligence fails to dispel all of the indicators that give rise to the suspicion that, if the order or series of orders is filled, the drugs that are the subject of the order or series of orders are likely to be diverted; and</text></subparagraph><subparagraph id="H3D9263439E3444F88BE155F861D69A6A"><enum>(D)</enum><text>notify the Administrator of the Drug Enforcement Administration and the Special Agent in Charge of the Division Office of the Drug Enforcement Administration for the area in which the registrant is located or conducts business of—</text><clause id="HF88DD467E00E4F428719003278A6D663"><enum>(i)</enum><text>each suspicious order or series of orders discovered by the registrant; and</text></clause><clause id="H5D1829C6E95D42EEBDCECC0A3E46471F"><enum>(ii)</enum><text display-inline="yes-display-inline">the indicators giving rise to the suspicion that, if the order or series of orders is filled, the drugs that are the subject of the order or series of orders are likely to be diverted.</text></clause></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H70DB36847BAA406AB6D74040E72880C7" commented="no"><enum>(b)</enum><header>Resolution of suspicious indicators</header><text display-inline="yes-display-inline">Section 312 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/832">21 U.S.C. 832</external-xref>) is amended—</text><paragraph id="HF106883AE2764BDF82061D0075AB7591" commented="no"><enum>(1)</enum><text>by redesignating subsections (b) and (c) as subsections (c) and (d), respectively; and</text></paragraph><paragraph id="HB3A01D5580774B2F83226A660E7A110B" commented="no"><enum>(2)</enum><text>by inserting after subsection (a) the following:</text><quoted-block style="OLC" id="H3067E22B3CA54D91973892742B2F8875" display-inline="no-display-inline"><subsection id="HB3FFDA4C90D94ACFA8CE6C7496F088FC" commented="no"><enum>(b)</enum><header>Resolution of suspicious indicators</header><text display-inline="yes-display-inline">If a registrant resolves all of the indicators giving rise to suspicion about an order or series of orders under subsection (a)(3)—</text><paragraph id="HB9B2F86981944182BED8D23CE3D54351" commented="no"><enum>(1)</enum><text>notwithstanding subsection (a)(3)(C), the registrant may choose to fill the order or series of orders; and</text></paragraph><paragraph id="HDE00B81BBE744ADAA7A6347BEB2D3D80" commented="no"><enum>(2)</enum><text>notwithstanding subsection (a)(3)(D), the registrant may choose not to make the notification otherwise required by such subsection.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection><subsection id="HDAEE37F0BEE6435F973BA9B5415CC8E7"><enum>(c)</enum><header>Regulations</header><text display-inline="yes-display-inline">Not later than 1 year after the date of enactment of this Act, for purposes of subsections (a)(3) and (b) of section 312 of the Controlled Substances Act, as amended or inserted by subsection (a), the Attorney General of the United States shall promulgate a final regulation specifying the indicators that give rise to a suspicion that, if an order or series of orders is filled, the drugs that are the subject of the order or series of orders are likely to be diverted.</text></subsection><subsection id="H1695551A4A53421B8821EE0569B30F8E"><enum>(d)</enum><header>Penalty</header><text>Section 402(a)(5) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/842">21 U.S.C. 842(a)(5)</external-xref>) is amended by inserting before the semicolon at the end the following: <quote>or otherwise violates section 312(a)(3)</quote>. </text></subsection><subsection id="H5C2E1CCCECBA47F5BDDAB92012E5A4D2"><enum>(e)</enum><header>Applicability</header><text display-inline="yes-display-inline">Subsections (a)(3) and (b) of section 312 of the Controlled Substances Act, as amended or inserted by subsection (a), shall apply beginning on the day that is 1 year after the date of enactment of this Act. Until such day, section 312(a)(3) of the Controlled Substances Act shall apply as such section 312(a)(3) was in effect on the day before the date of enactment of this Act.</text></subsection></section></legis-body></bill> 

